Company
Henry Schein, Inc.
Headquarters: Melville, NY, United States
Founded: Queens, New York1932
Employees: 21,600
CEO: Mr. Stanley M. Bergman
Market Cap
$9.32 Billion
USD as of Jan. 1, 2025
Henry Schein, Inc. Categories
United States Healthcare Medical DistributionUnited States Healthcare United States Medical Distribution
Top Competitors by Market Capitalization
Industry: Medical Distribution
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $75.80 B |
| Cencora, Inc. | $47.92 B |
| Cardinal Health, Inc. | $31.29 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $9.01 B |
| Sinopharm Group Co. Ltd | $8.15 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | $12.50 B |
| EBITDA | $909.0 M |
| Gross Profit TTM | $3.95 B |
| Profit Margin | 2.51% |
| Operating Margin | 6.55% |
| Quarterly Revenue Growth | 0.40% |
Stocks & Indices
Henry Schein, Inc. has the following listings and related stock indices.
Stock: NASDAQ: HSIC wb_incandescent
Stock: Bovespa: H1SI34 wb_incandescent
Stock: FSX: HS2 wb_incandescent
Key People
Founder(s): Henry Schein
Stanley M. Bergman (chairman and CEO) Jim Breslawski (President) Gerald A. Benjamin (Executive Vice President, CAO)